Replication-competent (oncolytic) adenovirus (Ad) vectors have been developed as a promising new tool in the fight against cancer. 1 The principal idea behind this approach is that the vector ...
Recent work highlights the potential usefulness of MVM-based vectors as selective vehicles for cancer gene therapy (Dupont et al, Gene Therapy, 2000; 7: 790–796). To implement this strategy, however, ...